- Home
- YI vs NSPR Comparison
YI vs NSPR Comparison
Compare YI & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YI
- NSPR
- Stock Information
- Founded
- YI 2010
- NSPR 2005
- Country
- YI China
- NSPR Israel
- Employees
- YI N/A
- NSPR N/A
- Industry
- YI Retail-Drug Stores and Proprietary Stores
- NSPR Medical/Dental Instruments
- Sector
- YI Consumer Staples
- NSPR Health Care
- Exchange
- YI Nasdaq
- NSPR Nasdaq
- Market Cap
- YI 64.4M
- NSPR 63.0M
- IPO Year
- YI N/A
- NSPR N/A
- Fundamental
- Price
- YI $0.63
- NSPR $2.53
- Analyst Decision
- YI
- NSPR Buy
- Analyst Count
- YI 0
- NSPR 1
- Target Price
- YI N/A
- NSPR $4.50
- AVG Volume (30 Days)
- YI 111.3K
- NSPR 36.3K
- Earning Date
- YI 11-27-2024
- NSPR 11-12-2024
- Dividend Yield
- YI N/A
- NSPR N/A
- EPS Growth
- YI N/A
- NSPR N/A
- EPS
- YI N/A
- NSPR N/A
- Revenue
- YI $2,026,540,888.00
- NSPR $6,821,000.00
- Revenue This Year
- YI $61.85
- NSPR $12.28
- Revenue Next Year
- YI N/A
- NSPR $53.44
- P/E Ratio
- YI N/A
- NSPR N/A
- Revenue Growth
- YI 0.38
- NSPR 24.70
- 52 Week Low
- YI $0.55
- NSPR $1.81
- 52 Week High
- YI $2.34
- NSPR $3.42
- Technical
- Relative Strength Index (RSI)
- YI 37.59
- NSPR 52.32
- Support Level
- YI $0.65
- NSPR $2.07
- Resistance Level
- YI $0.70
- NSPR $3.05
- Average True Range (ATR)
- YI 0.05
- NSPR 0.23
- MACD
- YI -0.01
- NSPR 0.02
- Stochastic Oscillator
- YI 11.59
- NSPR 46.94
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.